7.1199
0.49%
+0.0399
GoodRx Holdings Inc stock is currently priced at $7.1199, with a 24-hour trading volume of 460.68K.
It has seen a +0.49% increased in the last 24 hours and a +0.78% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $6.99 pivot point. If it approaches the $7.18 resistance level, significant changes may occur.
Previous Close:
$7.08
Open:
$7.28
24h Volume:
460.68K
Market Cap:
$2.80B
Revenue:
$750.27M
Net Income/Loss:
$-8.87M
P/E Ratio:
282.54
EPS:
0.0252
Net Cash Flow:
$82.53M
1W Performance:
+6.35%
1M Performance:
+0.78%
6M Performance:
+35.78%
1Y Performance:
+46.40%
GoodRx Holdings Inc Stock (GDRX) Company Profile
Name
GoodRx Holdings Inc
Sector
Industry
Phone
855 268 2822
Address
233 Wilshire Boulevard, Suite 990, Santa Monica
GoodRx Holdings Inc Stock (GDRX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
Dec-01-22 | Initiated | Citigroup | Buy |
Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
Sep-07-22 | Initiated | Truist | Hold |
Aug-12-22 | Initiated | DA Davidson | Neutral |
Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
Jun-06-22 | Resumed | BofA Securities | Buy |
Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
Apr-07-22 | Initiated | Guggenheim | Buy |
Apr-01-22 | Resumed | Credit Suisse | Neutral |
Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
Mar-01-22 | Reiterated | Barclays | Overweight |
Mar-01-22 | Reiterated | BofA Securities | Neutral |
Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
Mar-01-22 | Reiterated | Evercore ISI | Outperform |
Mar-01-22 | Reiterated | Goldman | Buy |
Mar-01-22 | Reiterated | JP Morgan | Underweight |
Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
Mar-01-22 | Reiterated | SVB Leerink | Outperform |
Jan-07-22 | Initiated | Goldman | Buy |
Dec-21-21 | Initiated | Stephens | Overweight |
Dec-02-21 | Initiated | Jefferies | Buy |
Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
May-28-21 | Initiated | Robert W. Baird | Neutral |
Apr-06-21 | Resumed | Evercore ISI | Outperform |
Jan-25-21 | Initiated | Guggenheim | Buy |
Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Oct-19-20 | Initiated | Barclays | Equal Weight |
Oct-19-20 | Initiated | BofA Securities | Neutral |
Oct-19-20 | Initiated | Citigroup | Buy |
Oct-19-20 | Initiated | Cowen | Outperform |
Oct-19-20 | Initiated | Credit Suisse | Outperform |
Oct-19-20 | Initiated | Deutsche Bank | Hold |
Oct-19-20 | Initiated | Goldman | Neutral |
Oct-19-20 | Initiated | JP Morgan | Neutral |
Oct-19-20 | Initiated | Morgan Stanley | Overweight |
Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
Oct-19-20 | Initiated | SVB Leerink | Outperform |
Oct-19-20 | Initiated | UBS | Buy |
View All
GoodRx Holdings Inc Stock (GDRX) Latest News
Is GoodRx (GDRX) Outperforming Other Medical Stocks This Year?
Zacks Investment Research
GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings
Benzinga
ELV vs. GDRX: Which Stock Is the Better Value Option?
Zacks Investment Research
Why GoodRx Surged Today
The Motley Fool
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says
Benzinga
GoodRx Holdings Inc Stock (GDRX) Financials Data
GoodRx Holdings Inc (GDRX) Revenue 2024
GDRX reported a revenue (TTM) of $750.26 million for the quarter ending December 31, 2023, a -2.12% decline year-over-year.
GoodRx Holdings Inc (GDRX) Net Income 2024
GDRX net income (TTM) was -$8.87 million for the quarter ending December 31, 2023, a +72.99% increase year-over-year.
GoodRx Holdings Inc (GDRX) Cash Flow 2024
GDRX recorded a free cash flow (TTM) of $82.53 million for the quarter ending December 31, 2023, a -9.87% decrease year-over-year.
GoodRx Holdings Inc (GDRX) Earnings per Share 2024
GDRX earnings per share (TTM) was -$0.02 for the quarter ending December 31, 2023, a +74.42% growth year-over-year.
GoodRx Holdings Inc Stock (GDRX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Wagner Scott | See Remarks |
Nov 30 '23 |
Buy |
5.76 |
21,652 |
124,806 |
182,900 |
Wagner Scott | See Remarks |
Nov 29 '23 |
Buy |
5.90 |
26,348 |
155,482 |
161,248 |
Wagner Scott | See Remarks |
Nov 28 '23 |
Buy |
6.00 |
4,157 |
24,940 |
134,900 |
Wagner Scott | See Remarks |
Nov 17 '23 |
Buy |
5.26 |
26,664 |
140,271 |
130,743 |
Wagner Scott | See Remarks |
Nov 16 '23 |
Buy |
5.16 |
104,079 |
537,204 |
104,079 |
About GoodRx Holdings Inc
GoodRx Holdings, Inc. is a holding company. The company, through its subsidiaries, owns and operates a prescription drug price comparison platform using data from local and mail-order pharmacies in the United States. It also provides pharmacy coupons to customers. The company offers generic and brand name pricing; alerts clients on manufacturer co-pay cards, pharmacy discounts, and state discount programs; and provides tips on slashing drug prices. It provides prices of drugs in areas of alcohol dependence, allergies, cold, Alzheimer's disease, angina, antibiotics, anticoagulant, antiviral, antiplatelet, anxiety, arrhythmia, arrhythmia, asthma, bipolar disorder, birth control, cancer, cerebral hemorrhage, cholesterol, COPD, depression, dermatology, diabetes, ear, enlarged prostate, epilepsy, eye, fertility, fibromyalgia, flu, gastrointestinal, heart failure, hypertension, hypotension, immune system, insomnia, medical supplies, men's health, mental health, migraine, myasthenia gravis, nausea, nervous system, obesity, obsessive-compulsive disorder, opioid dependence, pain relief, arthritis, panic disorder, Parkinson's disease, PMDD, restless leg syndrome, schizophrenia, seizure, sleep aids, smoking and addiction, smoking cessation, thyroid drugs, Tourette syndrome, trazodone, urology, vaccines, and women's health. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Cap:
|
Volume (24h):